醫療設備償付市場:付款者，醫療保健環境，各地區-規模，佔有率，展望，機會分析，2023年～2030年

市場動態:

慢性疾病的盛行率的增加，老年人口的增加，醫療費的增加，政府的輔助策略/計劃，全球醫療設備償付增大是預計促進全球醫療器械報銷市場增長的關鍵因素。

本調查的主要特徵

• 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球醫療設備償付市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發佈或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球醫療設備償付市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球醫療設備償付市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球醫療設備償付市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查的目的與前提條件

• 調查的目的
• 前提條件
• 簡稱

第2章 市場展望

• 報告概要
  • 市場定義和範圍
• 摘要整理
• 連貫·機遇·地圖(COM)

第3章 市場動態，法規，趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
• 影響分析
• 主要的焦點
• 法規方案
• 產品銷售/核准
• PEST分析
• PORTER的分析
• 合併·收購情勢

第4章 醫療設備償付市場-冠狀病毒(COVID-19)大流行病的影響

• 關於COVID-19流行病學
• 供給面和需求面的分析
• 經濟影響

第5章 醫療設備償付的全球市場，付款者，2017-2030年

• 公共
• 民間

第6章 醫療設備償付市場世界，醫療保健環境，2017年～2030年

• 醫院
• 門診病人設施
• 其他

第7章:醫療設備償付的全球市場，各地區，2017年～2030年

• 北美
• 歐洲
• 亞太地區
• 南美
• 中東·非洲地區

第8章 競爭情形

• BNP Paribas
• CVS Health
• Aviva
• Allianz
• Humana
• Cigna
• Aetna
• Wellcare Health Plans Inc.
• UnitedHealth Group Inc.
• Nippon Life Insurance Company

第9章 章節

• 關於調查手法
• 關於出版社

Medical devices reimbursement is a payment private insurer pays to healthcare providers for costs the provider incurred while using medical devices. Usually, health insurer or government payers cover the patients' healthcare expenses inclusive of medical device use. It is important because it ensures that patients have access to the medical devices they need.

Market Dynamics:

Increasing prevalence of chronic diseases, growing geriatric (aging) population, increasing cost of healthcare, and supportive government initiatives/programs are major factors expected to augment the growth of the global medical devices reimbursement market.

For instance, in November 2022, RQM+ announced the launch of its reimbursement division. RQM+ reimbursement services range from initial reimbursement strategy development to post-approval market access support. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical, and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

Key features of the study:

• This report provides in-depth analysis of the global medical devices reimbursement market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global medical devices reimbursement market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global medical devices reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical devices reimbursement market.

Detailed Segmentation:

• Global Medical Devices Reimbursement Market, By Payers:
  • Public
  • Private
• Global Medical Devices Reimbursement Market, By Healthcare Setting:
  • Hospitals
  • Outpatient Facilities
  • Others
• Global Medical Devices Reimbursement Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • BNP Paribas
  • CVS Health
  • Aviva
  • Allianz
  • Humana
  • Cigna
  • Aetna
  • Wellcare Health Plans Inc.
  • UnitedHealth Group Inc.,
  • Nippon Life Insurance Company

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Payers
  • Market Snapshot, By Healthcare Setting
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • High prevalence of chronic diseases and growing geriatric population
  • Complex framework and limited coverage and reimbursement
  • Increasing cost of healthcare and supportive government initiatives
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Medical Devices Reimbursement Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Medical Devices Reimbursement Market, By Payers, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Public
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Private
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Medical Devices Reimbursement Market, By Healthcare Setting, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Outpatient Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Medical Devices Reimbursement Market, By Region, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)

8. Competitive Landscape

• BNP Paribas
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CVS Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aviva
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Allianz
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Humana
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cigna
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aetna
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Wellcare Health Plans Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• UnitedHealth Group Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nippon Life Insurance Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us